Optimizing blood for life – solutions for improved quality of life and better health economy
Glycorex’s unique molecular level technology that specifically selects and removes antibodies in the blood has opened up revolutionary treatments and solutions in healthcare. The company’s medical devices enable transplants across the blood groups saving lives and providing health economic benefits by increasing the number of transplants. The company’s technology to treat blood is applied in several health care settings and a new unique product has recently been launched with the potential to increase availability of blood plasma. Several revolutionary products for the treatment of autoimmune diseases are under development.
One factor that keeps the number of transplants down is the limited availability of donated organs. This is where Glycorex can play a crucial role. We have developed a unique nano surgical technology that specifically selects and removes antibodies in the blood. This means that organ transplants can be done over the blood group barrier. Close relatives can thereby more easily donate a kidney regardless of blood type. Our method has been used clinically since 2001 and enabled more than 5,000 blood group incompatible transplants on four continents.
With our unique technology as a base, we are currently expanding into new interesting applications. In the area of transfusion medicine, we have recently launched a product intended to be used for donated plasma to produce universal blood plasma which can be given regardless of the recipient’s blood group, which means major improvements in logistics, safety and availability.
The focus of our development work is now to develop new treatments for severe autoimmune diseases. The closest to launch is a specific treatment for rheumatoid arthritis (RA) – a disease that has affected around five million people in Europe.
Scheelevägen 27 | SE-223 63 Lund, Sweden
Phone: +46 46 286 52 30 | Fax: +46 46-286 52 39
© 2022 Glycorex Transplantation AB. Registered office in Lund, Sweden . All rights reserved.